Drug intelligence / Profile preview

bakuchiol + ethyl linoleate

Development stage
Unknown
Lead developer
Sytheon
Modality
Small Molecules
Administration
Topical
01

Overview

Bakuchiol + ethyl linoleate is a topical combination of two natural ingredients, bakuchiol (a plant-derived functional analog of retinol) and ethyl linoleate (a fatty acid ester), developed for skincare applications. This combination exerts synergistic effects in keratinocytes by **inhibiting fatty acid binding protein 5 (FABP5)** and **fatty acid amide hydrolase (FAAH)**, resulting in increased levels of endocannabinoid (eCB) ligands (such as AEA, 2-AG, OEA, and PEA). This leads to enhanced activation of cannabinoid receptors (CB1, CB2) and TRPV1, with downstream suppression of inflammatory pathways (reduction of TNF, COX-2, type I interferon gene expression), reversal of TNF-induced gene shifts, and inhibition of cortisol secretion. Bakuchiol + ethyl linoleate also upregulates genes linked to cell proliferation and stemness while repressing those for keratinocyte differentiation. The formulation is primarily intended as an **innovative topical agent for managing inflammatory and compromised skin conditions** such as acne and atopic dermatitis. It is marketed by Sytheon under the brand name Asyntra D-Stress[1][2][4][5].

Brand names
Asyntra D-Stress
Other names
bakuchiol + ELNbakuchiol + ethyl (linoleate/oleate)
02

Targets

FABP3 (Fatty acid-binding protein 3)FAAHFABP5 (Fatty acid-binding protein 5)

Beyond the preview

Go deeper on bakuchiol + ethyl linoleate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bakuchiol + ethyl linoleate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call